During Sendai virus infection, Nmi can bind to IRF7, a master regulator for Type I IFN-dependent immune responses, and target IRF7 for proteasome-mediated degradation, leading to inhibition of Type I IFN responses induced by viral infections [56]. Here, IRF7 is linked to viral infectious disease.